Efect of Anaheal (Bromelain) Drug on the Periodontal Clinical Indices in Nonsurgical Periodontal Treatment of Patients with Chronic Periodontitis

Ali Zarandi, Masoumeh Faramarzi, Atabak Kashefi-Mehr, Ayda Ataie, Mahdi Rahbar

Abstract


Objective: To evaluate the effect of Anaheal (Bromelain) drug on the periodontal clinical indices in nonsurgical periodontal treatment of patients with chronic periodontitis. Material and Methods: In this double blind clinical trial, 80 patients with chronic moderate periodontitis and a healthy systemic status were chosen, and divided into two 40-subject groups. Thereafter, the standard treatment of periodontitis including scaling and root planning in one session by the unit operator was performed for all patients. Eventually, one group of the patients was administered Bromelain medication (500-mg capsule twice a day) one hour before food, while the other group was given placebo. Four and eight weeks after the treatment, the clinical periodontal indicators were measured and recorded in both groups. The data were assessed using descriptive statistics and analytical test methods (Mann-U-Whitney and Chi-square). P value less than 0.05 was considered statistically significant. Results: Gingival index, probing depth and plaque index before the treatment were similar in both groups (Anaheal and placebo). However, four and eight weeks after the treatment, the three studied indices were significantly lower in the Anaheal group as compared to the placebo (p<0.05). The index of bleeding on probing was also similar before the treatment and four weeks after the treatment in both groups. However, eight weeks after the treatment, this index was significantly lower in the Anaheal group as compared to the placebo group (p<0.05). Conclusion: Administration of oral Anaheal medication after nonsurgical periodontal treatments reduced all the clinical periodontal indices among patients with chronic periodontitis as compared to the control group. Therefore, it can be a suitable substitute for the common oral industrial antibiotics.

Keywords


Bromelains; Chronic Periodontitis; Periodontal Index; Root Planing.

Full Text:

PDF

References


Agarwal E, Bajaj P, Naik SB, Pradeep AR. Locally delivered 0.5% azithromycin as an adjunct to non-surgical treatment in patients with chronic periodontitis with type 2 diabetes: A randomized controlled clinical trial. J Periodontol 2017; 88(12):1281-7. doi: 10.1902/jop.2012.120172.

McGowan K, McGowan T, Ivanovski S. Optimal dose and duration of amoxicillin‐plus‐metronidazole as an adjunct to non‐surgical periodontal therapy: A systematic review and meta‐analysis of randomized, placebo‐controlled trials. J Clin Periodontol 2018; 45(1):56-67. doi: 10.1111/jcpe.12830.

Killoy WJ. Local delivery of antimicrobials: A new era in the treatment of adult periodontitis. Compend Contin Educ Dent 1999; 20(4 Suppl):13-8; quiz 34-5.

Drisko CH. The use of locally‐delivered doxycycline in the treatment of periodontitis. Clinical results. J Clin Periodontol 1998; 25(11 Pt 2):947-52. doi: 10.1111/j.1600-051X.1998.tb02396.x.

Killoy WJ. Chemical treatment of periodontitis: Local delivery of antimicrobials. Int Dent J 1998; 48(3 Suppl 1):305-15. doi: 10.1111/j.1875-595X.1998.tb00721.x.

Curilović Z, Mazor Z, Berchtold H. Gingivitis in Zurich schoolchildren. A reexamination after 20 years. SSO Schweiz Monatsschr Zahnheilkd 1977; 87(8):801-8.

Russell A. A system of classification and scoring for prevalence surveys of periodontal disease. J Dent Res 1956; 35(3):350-9. doi: 10.1177/00220345560350030401.

Hatano K, Kojima M, Tanokura M, Takahashi K. Solution structure of bromelain inhibitor IV from pineapple stem: Structural similarity with Bowman-Birk trypsin/chymotrypsin inhibitor from soybean. Biochemistry 1996; 35(17):5379-84. doi: 10.1021/bi952754.

Taussig SJ. The mechanism of the physiological action of bromelain. Med Hypotheses 1980; 6(1):99-104. doi: 10.1016/0306-9877(80)90038-9.

MacKay DJ, Miller AL. Nutritional support for wound healing. Altern Med Rev 2003; 8(4):359-77.

Taussig SJ, Yokoyama MM, Chinen A, Onari K, Yamakido M. Bromelain: A proteolytic enzyme and its clinical application. A review. Hiroshima J Med Sci 1975; 24(2-3):185-93.

Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci 2001; 58(9):1234-45. doi: 10.1007/PL00000936.

Vellini M, Desideri D, Milanese A, Omini C, Daffonchio L, Hernandez A, Brunelli G. Possible involvement of eicosanoids in the pharmacological action of bromelain. Arzneimittelforschung 1986; 36(1):110-2.

Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. J Ethnopharmacol 1988; 22(2):191-203. doi: 10.1016/0378-8741(88)90127-4.

Orsini RA. Safety and efficacy report bromelain. Plast Reconstr Surg 2006; 118(7):1640-4.

Golozar S, Abbaspour Z, Namjouian F, Latifi S M, Mirahi A. Evaluating the effect of oral bromelain (pineapple) on episiotomy wound healing in primiparus women. Feyz 2011; 15(2):84-90

Praveen NC, Rajesh A, Madan M, Chaurasia VR, Hiremath NV, Sharma AM. In vitro evaluation of antibacterial efficacy of pineapple extract (bromelain) on periodontal pathogens. J Int Oral Health 2014; 6(5):96-8.

Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967; 38(6):610-6. doi: 10.1902/jop.1967.38.6.610.

Majid OW, Al-Mashhadani BA. Perioperative bromelain reduces pain and swelling and improves quality of life measures after mandibular third molar surgery: A randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg 2014; 72(6):1043-8. doi: 10.1016/j.joms.2013.12.035.

Zare D, Haerian A, Molla R, Vaziri F. Evaluation of the effects of diode (980 nm) laser on gingival inflammation after nonsurgical periodontal therapy. J Lasers Med Sci 2014; 5(1):27-31.

Lang NP, Joss A, Orsanic T, Gusberti FA, Siegrist BE. Bleeding on probing. A predictor for the progression of periodontal disease?. J Clin Periodontol 1986; 13(6):590-6. doi: 10.1111/j.1600-051X.1986.tb00852.x.

Drisko CH. Non-surgical pocket therapy: Pharmacotherapeutics. Ann Periodontol 1996; 1(1):491-566. doi: 10.1902/annals.1996.1.1.491.

Dabaghi-Tabriz F, Fakhrzadeh V, Babaloo AR, Tagilu H, Eslami H, Rahbar M, Khadem-neghad S, Panahi P. Evaluation of periodontal status of adjacent teeth to posterior single-tooth implant during a one-year period after restoration: A cross-sectional study. Pesq Bras Odontoped Clin Integr 2018; 18(1):3872. doi: 10.4034/PBOCI.2018.181.17.

Babaloo A, Rahbar M, Babaloo Z, Ghasemi S, Amini A. Evaluation of clinical periodontal indices and serum interleukin-27 by one-stage full-mouth disinfection and quadrant scaling and root planing in periodontitis. J Contemp Dent Pract 2018; 19(8):997-1004.

Cobb CM. Clinical significance of non‐surgical periodontal therapy: An evidence‐based perspective of scaling and root planing. J Clin Periodontol 2002; 29(Suppl 2):6-16. doi: 10.1034/j.1600-051X.29.s2.4.x.

Ryan ME, Golub LM. Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontol 2000 2000; 24(1):226-38. doi: 10.1034/j.1600-0757.2000.2240111.x.

Chitsazi MT, Lafzi A, Eskandari A, Mortazavi A. A clinical comparison of Azithromycin versus Doxycycline in non-surgical periodontal treatment of smokers. Majallah-I-Dandanpizishki 2008; 19(4):70-5.

Pavan R, Jain S, Kumar A. Properties and therapeutic application of bromelain: A review. Biotechnol Res Int 2012; 2012:976203. doi: 10.1155/2012/976203.

Tochi BN, Wang Z, Xu SY, Zhang W. Therapeutic application of pineapple protease (bromelain): A review. Pakistan J Nutr 2008; 7(4):513-20. doi: 10.3923/pjn.2008.513.520.

Tadikonda A, Pentapati KC, Urala AS, Acharya S. Anti-plaque and anti-gingivitis effect of Papain, Bromelain, Miswak and Neem containing dentifrice: A randomized controlled trial. J Clin Exp Dent 2017; 9(5):e649-e653. doi: 10.4317/jced.53593.

Ghensi P, Cucchi A, Creminelli L, Tomasi C, Zavan B, Maiorana C. Effect of oral administration of bromelain on postoperative discomfort after third molar surgery. J Craniofac Surg 2017; 28(2):e191-e197. doi: 10.1097/SCS.0000000000003154.

Silva FRP, Vasconcelos ACCG, Alves EHP, Oliveira Junior PV, Oliveira JS, Vasconcelos DFP. Bromelain: A potential strategy for the adjuvant treatment of periodontitis. Dental Hypotheses 2016; 7(3):88-93. doi: 10.4103/2155-8213.190483.

Kalra N, Bhui K, Roy P, Srivastava S, George J, Prasad S, Shukla Y. Regulation of p53, nuclear factor κB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol Appl Pharmacol 2008; 226(1):30-7. doi: 10.1016/j.taap.2007.08.012.

Huang JR, Wu CC, Hou RC, Jeng KC. Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14. Immunol Invest 2008; 37(4):263-77. doi: 10.1080/08820130802083622.

Hou RC, Chen YS, Huang JR, Jeng KC. Cross-linked bromelain inhibits lipopolysaccharide-induced cytokine production involving cellular signaling suppression in rats. J Agric Food Chem 2006; 54(6):2193-8. doi: 10.1021/jf052390k.

Hajishengallis G, Chavakis T, Hajishengallis E, Lambris JD. Neutrophil homeostasis and inflammation: Novel paradigms from studying periodontitis. J Leukoc Biol 2015; 98(4):539-48. doi: 10.1189/jlb.3VMR1014-468R.

Hale LP, Greer PK, Sempowski GD. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol 2002; 104(2):183-90. doi: 10.1006/clim.2002.5254.




DOI: http://dx.doi.org/10.4034/PBOCI.2018.181.115

PBOCI IS A MEMBER OF CROSSREF AND ALL THE CONTENT OF ITS JOURNALS ARE LINKED BY DOIS THROUGH CROSSREF.